This is the authors' abstract. We don't add key points for this paper.
In the USA, up to 95% of individuals harbouring cancer-predisposing germline pathogenic variants have not been identified despite recommendations for screening at the primary care level.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bull et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: